Bet on 5 Top-Ranked Stocks With Rising P/E

Investors often opt for the stock-picking approach that involves stocks with a low price-to-earnings (P/E) ratio. This strategy is based on the notion that the lower the P/E ratio, the higher the stock value. The reasoning behind this is straightforward — when a stock's current market price does not adequately reflect its higher earnings, it suggests potential for growth.But there is more to this whole P/E story. Because not only low P/E, stocks with a rising P/E can also fetch strong returns. In this regard, investors can bet on the likes of Adverum Biotechnologies ADVM, IceCure Medical ICCM, DarioHealth DRIO, Energous WATT and Virgin Galactic SPCE.Rising P/E: A Useful ToolThe concept is that as earnings rise, so should the price of the stock. As forecasts for expected earnings come in higher, strong demand for the stock should continue to push up its prices. After all, astock's P/E gives an indication of how much investors are ready to shell out per dollar of earnings.Suppose an investor wants to buy a stock with a P/E ratio of 30. This means that he is willing to shell out $30 for only $1 worth of earnings as he expects earnings of the company to rise at a faster pace in the future owing to strong fundamentals.So, if the P/E of a stock is rising steadily, it means that investors are assured of its inherent strength and expect some strong positives out of it.Also, studies have revealed that stocks have seen their P/E ratios jump over 100% from their breakout point in the cycle. So, if you can pick stocks early in their breakout cycle, you can end up seeing considerable gains.The Winning StrategyIn order to shortlist stocks that are exhibiting an increasing P/E, we chose the following as our primary screening parameters.EPS growth estimate for the current year is greater than or equal to last year’s actual growthPercentage change in last year EPS should be greater than or equal zero(These two criteria point to flat earnings or a growth trend over the years.)Percentage change in price over four weeks greater than the percentage change in price over 12 weeksPercentage change in price over 12 weeks greater than percentage change in price over 24 weeks(These two criteria show that price of the stock is increasing consistently over the said timeframes.)Percentage price change for four weeks relative to the S&P 500 greater than the percentage price change for 12 weeks relative to the S&P 500Percentage price change for 12 weeks relative to the S&P 500 greater than the percentage price change for 24 weeks relative to the S&P 500(Here, the case for consistent price gains gets even stronger as it displays percentage price changes relative to the S&P 500.)Percentage price change for 12 weeks is 20% higher than or equal to the percentage price change for 24 weeks, but it should not exceed 100%(A 20% increase in the price of a stock from the breakout point gives cues of an impending uptrend. But a jump of over 100% indicates that there is limited scope for further upside and that the stock might be due for a reversal.)In addition, we place a few other criteria that lead us to some likely outperformers.Zacks Rank less than or equal to 2: Only companies with a Zacks Rank #1 (Strong Buy) or 2 (Buy) can get through.Average 20-day Volume greater than or equal to 50,000: High trading volume implies that the stocks have adequate liquidity.Just these few criteria narrowed down the universe from over 7,700 stocks to just 45.Here are five out of the 45 stocks:Adverum Biotechnologies: The Zacks Rank #2  company is a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases. You can see the complete list of today’s Zacks #1 Rank stocks here.The average four-quarter earnings surprise of ADVM is 5.15%.IceCure Medical: The Zacks Rank #2 company develops and markets an advanced liquid-nitrogen-based cryoablation therapy for the treatment of tumors by freezing, with the primary focus areas being breast, kidney, bone and lung cancer.The average four-quarter earnings surprise of ICCM is 4.76%.DarioHealth: The Zacks Rank #2 company creates mobile and digital tools. The company's product the Dario Smart Diabetes Management Solution, is a platform for diabetes management, which combines the blood glucose meter, the native smartphone app, website portal and treatment tools to users living with diabetes, their doctors and healthcare systems.The average four-quarter earnings surprise of DRIO is 53.22%.Energous: The Zacks Rank #2 company is a developer of a disruptive wire-free charging technology.The average four-quarter earnings surprise of WATT is 10.30%.Virgin Galactic: The Zacks Rank #2 company is a vertically integrated aerospace company pioneering human spaceflight for private individuals and researchers.The average four-quarter earnings surprise of SPCE is 18.28%.You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.Click here to sign up for a free trial to the Research Wizard today.Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.Disclosure: Performance information for Zacks’ portfolios and strategies are available at: https://www.zacks.com/performance.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.7% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Energous Corporation (WATT): Free Stock Analysis Report Adverum Biotechnologies, Inc. (ADVM): Free Stock Analysis Report DarioHealth Corp. (DRIO): Free Stock Analysis Report Virgin Galactic Holdings, Inc. (SPCE): Free Stock Analysis Report IceCure Medical Ltd. (ICCM): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks